Learn about Neurotorium and meet our editorial board

About Neurotorium

About Neurotorium

At Neurotorium.org, our mission is to improve awareness and knowledge of the brain and its diseases. We provide unbiased and freely available, online educational content created for clinicians, educators and all who are interested in learning more about the brain. All our educational material is developed, reviewed, and regularly updated by leading experts within the fields of psychiatry, neurology, and neuroscience. Through awarding of educational grants, Neurotorium also enables others around the world to develop and deliver high-quality education about the brain. Neurotorium also organises scientific meetings and events at international conferences to facilitate dialogue within and between the fields of neurology and psychiatry. Neurotorium.org is a non-commercial, non-profit initiative founded by the Lundbeck Foundation, Lundbeckfonden.com.

Meet Our Editorial Board

Professor Christoph Correll
Christoph Correll
Chair Editorial Board
chevron_right
Professor Messoud Ashina
Messoud Ashina
Editorial Board
chevron_right
Professor Gretchen Birbeck
Gretchen Birbeck
Editorial Board
chevron_right
Professor Katharina Domschke
Katharina Domschke
Editorial Board
chevron_right
Professor Gabriele Fischer
Gabriele Fischer
Editorial Board
chevron_right
Professor Matthew Kiernan
Matthew Kiernan
Editorial Board
chevron_right
Professor Shen-Yang Lim
Shen-Yang Lim
Editorial Board
chevron_right
Professor Lakshmi Yatham
Lakshmi Yatham
Editorial Board
chevron_right
Professor Christoph Correll

Professor Christoph Correll

Christoph Correll, MD: professor of psychiatry at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and a medical director of the Recognition and Prevention (RAP) program at Zucker Hillside Hospital. He also currently serves as professor and chair of the Department of Child and Adolescent Psychiatry at Charité University Medicine in Berlin, Germany.

Professor Correll has authored and co-authored more than 900 journal articles that have been cited over 76,000 times, and in April 2024 his Google Scholar h-index was 143. He has been the Principal Investigator or Steering Committee member of several large, federally funded grants and has served on several expert consensus panels on the use of antipsychotics across a range of psychiatric disorders. He has received more than 40 national and international research awards and fellowships for his work. Since 2014, the year of inception of this metric, Professor Correll has been listed each year by Thomson Reuters/Clarivate/Web of Science as one of “The most influential scientific minds” and “Top 1% cited scientists in the area of psychiatry.”
Research focus.

Professor Correll’s research and clinical work focus on the identification, characterization and psychopharmacological management of adults and youth with severe psychiatric disorders. His areas of expertise include schizophrenia, bipolar disorder, major depression and other psychotic, mood and autism/disruptive behavior spectrum disorders, ranging from the prodrome to first episode, multi-episode and refractory illness patients. His work focuses further on psychopharmacology, epidemiology, clinical trials, comparative effectiveness, meta-analyses, the risk–benefit evaluation of psychotropic medications, and the interface between physical health and mental health.

Professor Messoud Ashina

Professor Messoud Ashina

Messoud Ashina, MD, PhD, DMSc, FEAN, holds the position of Professor of Neurology and serves as the Director of the Human Migraine Research Unit at the Department of Neurology & Danish Headache Center, Rigshospitalet, the University of Copenhagen, Denmark.

Professor Messoud Ashina’s distinguished career includes the roles of Past President of the International Headache Society (2019–2021) and Past General Secretary of the European Headache Federation. Prof. Ashina is recognized as a Fellow of the European Academy of Neurology. He also contributes as an Associate Editor for prestigious journals including Brain, The Journal of Headache and Pain.
Prof. Ashina’s extensive research focuses on understanding the complexities of migraine and cluster headache pathophysiology. He investigates the mechanisms of action of antimigraine medications, conducts pioneering work with experimental migraine models, utilizes functional neuroimaging techniques, and explores novel targets for antimigraine drug development. His scholarly contributions comprise over 600 papers, abstracts, and book chapters, primarily focusing on headaches, including both migraine and cluster headache.

Professor Gretchen Birbeck

Professor Gretchen Birbeck

Professor Gretchen Birbeck is the Rykenboer Professor of Neurology at the University of Rochester where she also serves as Research Director for the Epilepsy Division. She is a consultant at Zambia’s University Teaching Hospitals Children’s Hospital in Lusaka and serves as Director for the Chikankata Epilepsy Care Team in Mazabuka, Zambia . Her work includes supporting numerous EEG Labs in Africa including at Queen Elizabeth Central Hospital in Blantyre, Malawi.

Since 1994, Professor Gretchen Birbeck has served as a physician, medical educator, and researcher in sub-Saharan Africa. Her overarching professional goal is to elucidate the mechanisms of common neurology disorders in the region, identify opportunities for feasible, affordable, evidence-based interventions aimed at preventing or ameliorating neurologic illness/injury, and move these interventions forward into clinical trials. Professor Gretchen Birbeck’s research priorities are directly informed by their experience as a clinician and educator in Zambia and Malawi. Having originally trained as an adult neurologist in the US, her postdoctoral studies in health services research, epidemiology, pediatric epilepsy, and tropical medicine were all selected based upon the skills needed to pursue these overarching professional goals. Given the dearth of neurologic expertise in Africa and the heavy burden of disease there, her research program spans a broad range of conditions and is made possible through strong collaborations with in-country colleagues and US-based neuroscientists with advanced sub-specialty expertise. Capacity building through mentoring of both US and African scientists is a cornerstone of Professor Gretchen Birbeck’s endeavors. Their Africa-based work has received continuous support from the US NIH for over two decades and is presently supported by R35NS122265 Global Research Endeavors to Advance Treatment of Neurological Disorders in Africa; and R01NS111057 An MRI Ancillary Grant on a Malaria Fever Control RCT. In addition to their own funding, they are presently a mentor for five active NIH career development awardees.

Professor Katharina Domschke

Professor Katharina Domschke

Full Professor and Chair of the Department of Psychiatry and Psychotherapy, University of Freiburg, Germany; Adjunct Professor at the Medical University Vienna, Austria

Prof. Katharina Domschke, MA, MD, PhD, is Full Professor and Chair of the Dept. of Psychiatry and Psychotherapy, University of Freiburg, Germany, and Adjunct Professor at the Medical University Vienna, Austria. Her clinical and teaching focus is on the treatment and prevention of anxiety, stress-related and affective disorders. Scientifically, Prof. Domschke is a renowned expert in genetics, epigenetics, imaging genetics and pharmacogenetics in the targeted treatment and prevention of anxiety, stress-related and affective disorders as reflected by to date ~440 publications in international journals and an h-index of 60 (Web of Science). She has received funding from the EU, the German Research Foundation (DFG) and the German Ministry of Research and Education (BMBF) and is a full member or fellow of ACNP, ECNP, ISPG, SOBP and the German National Academy of Sciences Leopoldina. Prof. Domschke is president of the ECNP Anxiety Disorders Research Network (ADRN), vice president of the German Society of Anxiety Research (GAF) and a board member of the German Society of Psychiatry, Psychosomatics and Psychotherapy (DGPPN) and serves on the editorial boards of 10 international journals. Her work has been recognized by e.g. the WFSBP Research Award, the WPA Fellowship Award and the ECNP Fellowship Award.

Professor Gabriele Fischer

Professor Gabriele Fischer

Prof. Dr. Gabriele Fischer works as psychiatrist and human rights specialist at the Medical University Vienna, where she has been acting for many years as director of the Addiction clinic with a double affiliation to the Center of Public Health and Department of Psychiatry & Psychotherapy.

Through her academic career, Prof. Dr. Gabriele Fischer has published more than 160 peer-reviewed scientific papers, many books in addition to > 600 international oral presentations, next to many international educational trainings in substance use disorder and related co-morbidities. Her research funds in the field of substance use disorder have been recruited internationally through NIH/NIDA, EU, Council of Europe, third parties as well as numerous grants through national grant funding. For many decades she has been engaged as consultant for UN, WHO, EMCDDA and other international organizations, next to her research focus is neuropsychopharmacology, neuroscience, co-morbidity (like ADHD), sex/gender related aspects, cost-economy, vulnerable populations (prisoners, migrants) and human rights aspects in psychiatry with special consideration of substance use disorder. She serves in the expert pool of CPT (Committee for the prevention of torture) at the Council of Europe next to many board & committee activities related to psychiatry/substance use disorder on a national and international level. Finally, she has been involved for many years as member of the scientific committee at the European Monitoring Center for Drugs & Drug Addiction (EMCDDA) in Lisbon.

Professor Matthew Kiernan

Professor Matthew Kiernan

Professor Matthew Kiernan, AM, MBBS (Honours), PhD, DSc, FRACP, FAHMS

Professor Matthew Kiernan is the Chief Executive Officer and Institute Director, Neuroscience Research Australia. He holds appointments as the Scientia Professor of Neuroscience at the University of New South Wales, Sydney, Australia and is a Senior Staff Specialist in Neurology at South Eastern Sydney Local Health District. Professor Kiernan is past President of the Australian & New Zealand Association of Neurologists, having helped shape neuroscientific research and the training of neurologists across Australia and New Zealand.
Professor Kiernan is Chair of the World Federation of Neurology Specialty Group in Neurodegenerative Disease, Chair of the World Congress of Neurology, President of the Brain Foundation and Editor Emeritus of the Journal of Neurology, Neurosurgery & Psychiatry (BMJ Publishers, United Kingdom), having served as Editor-in-Chief from 2010-2022.

Professor Shen-Yang Lim

Professor Shen-Yang Lim

Professor Dr. Lim, MBBS MD FRACP FASc, is a Neurologist and Professor at the University of Malaya, Kuala Lumpur, Malaysia, where he runs a busy clinical practice specializing in Parkinson's and related disorders.

Dr. Lim has also published extensively within the areas of Parkinson’s disease and related disorders, in major scientific journals including Lancet Neurology, JAMA Neurology, Neurology, Nature Genetics, Nature Reviews Neurology, Movement Disorders, etc. He has been an active member of the International Parkinson & Movement Disorder Society (MDS), being closely involved in multiple task forces and committees, e.g., on Parkinson’s disease classification. He is currently Chair of the MDS Asian-Oceanian Section (AOS).

He is a versatile and sought-after speaker and has delivered numerous Plenary Lectures, including at MDS Congresses (Toronto 2011, Dublin 2012, Nice 2019, Philadelphia/Virtual 2020, Copenhagen 2023) and at the World Parkinson’s Congress (Kyoto 2019). He has represented the MDS as Visiting Professor and Ambassador in many underserved countries throughout the AOS.

Dr. Lim’s main research interests are in the following areas: (i) PD (particularly genetics and genotype-phenotype correlations; evidence-based medicine/clinical trials; non-motor features including gastrointestinal aspects; comorbidities; patient-centred care; and rating scales/disease staging); (ii) Parkinson-plus syndromes and other miscellaneous/”orphan” movement disorders, including progressive supranuclear palsy (PSP).

Professor Lakshmi Yatham

Professor Lakshmi Yatham

Lakshmi N. Yatham is a Professor and Head of the Department of Psychiatry and Director of the Institute of Mental Health at the University of British Columbia in Vancouver, Canada. He is also the Regional Head of Psychiatry and Regional Program Medical Director for Mental Health and Addictions at Vancouver Coastal Health and Providence Healthcare. He has an executive MBA in health care from the Sauder School of Business.

Dr. Yatham has held leadership positions for national and international professional organizations including the President of the International Society for Bipolar Disorders, the Secretary for the World Federation of Societies of Biological Psychiatry (WFSBP), and he is now the President of the WFSBP. He is the Editor in Chief for the Canadian Journal of Psychiatry, Field Editor at Large for Bipolar Disorders, and on the editorial boards of many international journals.

Dr. Yatham’s areas of interests include neurobiology and treatment of bipolar disorder. He has a google scholar h-index of 93, and he has published over 430 papers in peer-reviewed international journals including New England Journal of Medicine, World Psychiatry, Lancet Psychiatry, JAMA Psychiatry etc with over 35,000 citations to his work. Dr. Yatham was listed in the Clarivate Analytics 2017 to 2021 reports and Thomson Reuters’ reports on “World’s Most Influential Scientific Minds -2014 and 2015” as one of the most highly cited researchers (publications with top 1% of citations) in psychiatry/psychology in the world based on research published since 2002. He is the principal author of widely read and cited CANMAT/ISBD guidelines for treatment of bipolar disorders, has edited books and written a number of book chapters including a chapter on Treatment of mood disorders for the current 10th and the upcoming 11th editions of the Kaplan and Sadock’s Comprehensive Textbook of Psychiatry. Dr. Yatham is a sought after speaker and has presented his research work at numerous international conferences.

He has won numerous prestigious national and international awards for his contributions including Mogen Schou Award for international education and advocacy on bipolar disorder from the International Society for Bipolar Disorders (ISBD), Heinz Lehman Award as well as the Canadian College of Neuropsychopharmacology Medal for his contributions to psychopharmacology, John M Cleghorn Award for excellence in research and leadership from the Canadian Psychiatric Association, Frank and Kupfer Award from the ISBD for distinctive and sustained contributions to the field of bipolar disorder, Robert Post Mentorship Award from the ISBD for mentoring and facilitating careers of junior researchers and clinicians, Gerald L Klerman Award from Depression and Bipolar Support Alliance in the USA for significant contribution towards advancing causes, diagnosis and treatment of mood disorders and the Colvin Research Prize in Mood Disorders from the Brain and Behaviour Foundation in the USA for his outstanding contributions to research in mood disorders.

Meet the Neurotorium Team

Martin Meyer
Martin Meyer
Scientific Programme Director
chevron_right
Ceren Akdeniz Vogt
Ceren Akdeniz Vogt
Senior Scientific Programme Manager
chevron_right
Mathias Velløv Petersen
Mathias Velløv Petersen
Digital Media Specialist
chevron_right
Bryn Farnsworth von Cederwald
Bryn Farnsworth von Cederwald
Scientific Programme Manager
chevron_right
Viktoria-Maria Hvidtfelt Lykke
Viktoria-Maria Hvidtfelt Lykke
Student Analyst
chevron_right
Cecilie Rørdam
Cecilie Rørdam
Student Analyst
chevron_right
Martin Meyer

Martin Meyer

Martin is Director of The Brain Prize and Neurotorium.

Martin joined Neurotorium in 2023. From 2000 to 2020 he was engaged in neuroscience research within an academic environment. From 2006 to 2020 he was a group leader and Reader in Neuroscience in the Centre for Developmental Neurobiology & MRC Centre for Neurodevelopmental Disorders, King’s College London. From 2000 to 2006 he was a postdoctoral fellow in the Department of Molecular and Cellular Physiology, Stanford University.

He has been Director of The Brain Prize at the Lundbeck Foundation since 2020.

Martin holds a Bachelor’s degree in Biology and a PhD in Cell and Developmental Biology from University College London.

Ceren Akdeniz Vogt

Ceren Akdeniz Vogt

Ceren Akdeniz Vogt is responsible for Neurotorium's medical-scientific content development, strategic partnerships, and outreach activities. Ceren is also involved in digital communications, including social media and newsletters.

Ceren joined Neurotorium in March 2023 and she previously worked in various positions in the medical science industry.

Ceren holds a Master of Science (MSc) in Neural and Behavioral Sciences from the University of Tübingen and a doctoral degree (Dr.sc.hum.) in Psychiatry from the University of Heidelberg.

Mathias Velløv Petersen

Mathias Velløv Petersen

Mathias joined Neutororium in August 2022, where he became responsible for digital communications.

Mathias brings experience within strategic digital communications from the agency Perfekta PR, where he previously held the position as Head of Digital. Mathias holds a master’s in Communications from Aalborg University.

Bryn Farnsworth von Cederwald

Bryn Farnsworth von Cederwald

Bryn is responsible for expanding scientific content development, and Neurotorium's educational grants.

Bryn joined Neurotorium in April 2024. He has previous experience in research from the University of Nottingham, Uppsala University, and Umeå University, with a focus on aging and dementia.
He most recently worked for a human behavior research software company as a Science Communication Manager.

Bryn holds an MSc from the University of Sheffield, and a PhD from Uppsala University.

Viktoria-Maria Hvidtfelt Lykke

Viktoria-Maria Hvidtfelt Lykke

Viktoria is a student analyst with Neurotorium.

Viktoria joined Neurotorium in September 2022 and is studying for a bachelor’s degree in Public Health Science at Copenhagen University.
Following her studies, Viktoria has completed a research internship at the Queensland Center for Mental Health Research and participated in the University of Copenhagen’s SUND Hub Health Innovators program.

In addition, Viktoria has previously worked as a personal assistant for a privately practising psychiatrist and in the Department of Health Services Research at the University of Copenhagen.

Cecilie Rørdam

Cecilie Rørdam

Cecilie supports communication and marketing with Neurotorium.

Cecilie started at Neurotorium in January 2024 while studying a master’s degree at Copenhagen Business School in Corporate Communication and Business Economics. She previously worked with marketing and communications as a student assistant at Schneider Electric from 2021-2024.

Cecilie has a bachelor’s degree in Communications from Copenhagen Business School.

task_alt